STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and moreWorldPing
Image via STAT.

What happened

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks…

Key facts

  • A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks…
  • Reported by STAT and published Thu, 10 Sep 2026 13:09:22 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill

  2. STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Elon Musk attacks film-maker behind documentary about himWorldPing
The Guardian

Elon Musk attacks film-maker behind documentary about him

Tech mogul calls director Alex Gibney a ‘bitter old man’ who has ‘zero integrity’ in series of posts on X Elon Musk has issued an angry tirade at the film-maker behind a four-hour documentary about his life and influence, labelling the director Alex…

Brief by WorldPing · Original reporting by The Guardian